Login / Signup

Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma.

Gang NingYan-Lin HuangLi-Min ZhenWen-Xiong XuXue-Jun LiLi-Na WuYing LiuChan XieLiang Peng
Published in: BioMed research international (2020)
C2 is a prognostic factor for HCC and may be used as a therapeutic target for future treatment of HCC.
Keyphrases
  • prognostic factors
  • current status
  • combination therapy
  • replacement therapy